These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11115835)

  • 21. Colonic bacterial proteases to IgA1 and sIgA in patients with ulcerative colitis.
    Barr GD; Hudson MJ; Priddle JD; Jewell DP
    Gut; 1987 Feb; 28(2):186-9. PubMed ID: 3549472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics in the Management of Ulcerative Colitis.
    Chibbar R; Dieleman LA
    J Clin Gastroenterol; 2015; 49 Suppl 1():S50-5. PubMed ID: 26447965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.
    Scaldaferri F; Gerardi V; Mangiola F; Lopetuso LR; Pizzoferrato M; Petito V; Papa A; Stojanovic J; Poscia A; Cammarota G; Gasbarrini A
    World J Gastroenterol; 2016 Jun; 22(24):5505-11. PubMed ID: 27350728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotic therapy for ulcerative colitis.
    Floch MH
    J Clin Gastroenterol; 2010 Apr; 44(4):237-8. PubMed ID: 20087200
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease.
    Elliott TR; Hudspith BN; Wu G; Cooley M; Parkes G; Quiñones B; Randall L; Mandrell RE; Fagerquist CK; Brostoff J; Rayment NB; Boussioutas A; Petrovska L; Sanderson JD
    Inflamm Bowel Dis; 2013 Oct; 19(11):2326-38. PubMed ID: 23989750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Morphological and immunological characteristics of various clinical forms of nonspecific ulcerative colitis].
    Avtandilov GG; Larchenko NT; Stenina MA; Loranskaia ID; Cheredeev AN
    Arkh Patol; 1984; 46(10):18-25. PubMed ID: 6334508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?
    Marteau P
    Gut; 2006 Dec; 55(12):1692-3. PubMed ID: 17124152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
    Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
    World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbial-host interactions in inflammatory bowel diseases and experimental colitis.
    Sartor RB
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():121-32; discussion 132-7, 251-7. PubMed ID: 19710519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunocompetent cell content in the blood and mucosa of the small intestine in nonspecific ulcerative colitis].
    Larchenko NT; Stenina MA; Avtandilov GG; Cheredeev AN
    Sov Med; 1983; (9):9-14. PubMed ID: 6606234
    [No Abstract]   [Full Text] [Related]  

  • 31. [Etiopathogenesis and aggravating factors in ulcerative colitis].
    Inoue S; Nakase H; Chiba T
    Nihon Rinsho; 2005 May; 63(5):757-62. PubMed ID: 15881166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysis.
    Losurdo G; Iannone A; Contaldo A; Ierardi E; Di Leo A; Principi M
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):499-505. PubMed ID: 26697577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ detection of interleukin-1 beta and interleukin 8 in biopsy specimens from patients with ulcerative colitis.
    Radema SA; Tytgat GN; van Deventer SJ
    Adv Exp Med Biol; 1995; 371B():1297-9. PubMed ID: 7502804
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.
    Yoshimatsu Y; Yamada A; Furukawa R; Sono K; Osamura A; Nakamura K; Aoki H; Tsuda Y; Hosoe N; Takada N; Suzuki Y
    World J Gastroenterol; 2015 May; 21(19):5985-94. PubMed ID: 26019464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell activation and proliferation in the large intestine of patients with Crohn's disease or ulcerative colitis and controls.
    Ullrich R; Schneider T; Schieferdecker HL; Jahn HU; Riecken EO; Zeitz M
    Adv Exp Med Biol; 1995; 371B():1281-2. PubMed ID: 7502800
    [No Abstract]   [Full Text] [Related]  

  • 36. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of ulcerative colitis by implantation of normal colonic flora.
    Bennet JD; Brinkman M
    Lancet; 1989 Jan; 1(8630):164. PubMed ID: 2563083
    [No Abstract]   [Full Text] [Related]  

  • 38. [The assessment of the local immune reaction of the mucosa of the large intestine in patients with nonspecific ulcerative colitis].
    Dudar' LV; Bychkova NG
    Lik Sprava; 1994 Jan; (1):81-3. PubMed ID: 8067029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Etiology and pathogenesis of Crohn disease and ulcerative colitis].
    Knoflach P
    Wien Klin Wochenschr; 1986 Nov; 98(22):754-8. PubMed ID: 3811368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T lymphocyte subpopulations and immunoglobulin-containing cells in the colonic mucosa of ulcerative colitis; a morphometric and immunohistochemical study.
    Kobayashi K; Asakura H; Hamada Y; Hibi T; Watanabe M; Yoshida T; Watanabe N; Miura S; Aiso S; Tsuchiya M
    J Clin Lab Immunol; 1988 Feb; 25(2):63-8. PubMed ID: 2897471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.